Depo-Provera Injection: Effects on Menstruation, Ovulation, and Cycle Changes

Depo-Provera (depot medroxyprogesterone acetate, DMPA) is a progestin-only injectable contraceptive given every 12–13 weeks. It suppresses ovulation, thickens cervical mucus, and thins the endometrium.

Menstrual Pattern Changes

  • Irregular bleeding/spotting: Most common in the first 3–6 months.
  • Amenorrhea (no periods): ~50% of users at 1 year; ~70% at 2 years.
  • Prolonged or heavy bleeding: Less common but possible.

These changes are due to endometrial atrophy and destabilization from continuous progestin exposure without estrogen.

Ovulation Risk

Ovulation is highly suppressed when injections are on schedule. However, if an injection is delayed beyond 13 weeks, ovarian activity can resume. Bleeding before the next scheduled shot does not reliably indicate ovulation; it is usually breakthrough bleeding from a thin endometrium.

Pregnancy Risk

Typical-use failure rate is ~6% (mostly due to late injections). Perfect-use failure rate is <0.5%. If you suspect pregnancy (e.g., missed injection + pregnancy symptoms), take a test and contact your provider.

Return to Fertility

After stopping, median time to ovulation is 9–10 months; it can take up to 18 months for some women. Counsel patients who desire pregnancy soon to consider other methods.

Clinical Tips

  • Schedule injections every 11–12 weeks for a buffer.
  • NSAIDs or short-course estrogen can manage problematic bleeding.
  • Bone density monitoring recommended after 2 years of continuous use.

Infertility - Related Articles